Next Article in Journal
Crystal Structure of the Full-Length Feline Immunodeficiency Virus Capsid Protein Shows an N-Terminal β-Hairpin in the Absence of N-Terminal Proline
Previous Article in Journal
The 17th Rocky Mountain Virology Association Meeting
Open AccessArticle

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals

1
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Private Bag X7, Congella, Durban 4013, South Africa
2
Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Private Bag X7, Congella, Durban 4013, South Africa
3
Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven–University of Leuven, 3000 Leuven, Belgium
4
Artificial Intelligence Lab, Department of Computer Science, Vrije Universiteit Brussel, Brussels, 1050 Elsene, Belgium
5
Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA 30322, USA
6
Infectious Diseases Unit, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Private Bag X7, Congella, Durban 4013, South Africa
7
Africa Health Research Institute, University of KwaZulu-Natal, Private Bag X7, Congella, Durban 4013, South Africa
8
Ragon Institute of MGH, MIT and Harvard University, Cambridge, MA 01239, USA
9
Max Planck Institute for Infection Biology, Chariteplatz, D-10117 Berlin, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2017, 9(11), 330; https://doi.org/10.3390/v9110330
Received: 26 September 2017 / Revised: 2 November 2017 / Accepted: 4 November 2017 / Published: 8 November 2017
(This article belongs to the Section Antivirals & Vaccines)
The South African national treatment programme includes nucleoside reverse transcriptase inhibitors (NRTIs) in both first and second line highly active antiretroviral therapy regimens. Mutations in the RNase H domain have been associated with resistance to NRTIs but primarily in HIV-1 subtype B studies. Here, we investigated the prevalence and association of RNase H mutations with NRTI resistance in sequences from HIV-1 subtype C infected individuals. RNase H sequences from 112 NRTI treated but virologically failing individuals and 28 antiretroviral therapy (ART)-naive individuals were generated and analysed. In addition, sequences from 359 subtype C ART-naive sequences were downloaded from Los Alamos database to give a total of 387 sequences from ART-naive individuals for the analysis. Fisher’s exact test was used to identify mutations and Bayesian network learning was applied to identify novel NRTI resistance mutation pathways in RNase H domain. The mutations A435L, S468A, T470S, L484I, A508S, Q509L, L517I, Q524E and E529D were more prevalent in sequences from treatment-experienced compared to antiretroviral treatment naive individuals, however, only the E529D mutation remained significant after correction for multiple comparison. Our findings suggest a potential interaction between E529D and NRTI-treatment; however, site-directed mutagenesis is needed to understand the impact of this RNase H mutation. View Full-Text
Keywords: HIV-1; RNase H; resistance; mutations; NRTIs HIV-1; RNase H; resistance; mutations; NRTIs
Show Figures

Figure 1

MDPI and ACS Style

Ngcapu, S.; Theys, K.; Libin, P.; Marconi, V.C.; Sunpath, H.; Ndung’u, T.; Gordon, M.L. Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals. Viruses 2017, 9, 330.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop